China, Nov. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Single-Arm Study of Everolimus Tablets for the Treatment of Tuberous Sclerosis Complex'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136496
Registration Time: 2026/11/11
Type: Interventional study
Primary Sponsor: Henan Provincial People's Hospita,medical
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=351717
Published by HT Digital Content Services with permission from Health Daily Digest....